Ocrelizumab use in the real-world experience: data from a hot spot area for Multiple Sclerosis

被引：0
|
作者：
Mellino, P. [1 ]
Lorefice, L. [1 ]
Pilotto, S. [1 ]
Frau, J. [1 ]
Pintus, M. [1 ]
Barca, S. [1 ]
Coghe, G. [1 ]
Barracciu, M. [2 ]
Cocco, E. [1 ]
机构：
[1] Univ Cagliari, Multiple Sclerosis Ctr, Dept Med Sci & Publ Hlth, ASL Cagliari,Binaghi Hosp, Cagliari, Italy
[2] ASL Cagliari, Binaghi Hosp, Radiol Unit, Cagliari, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-497
引用
收藏
页码：634 / 635
页数：2
相关论文
共 50 条
  • [31] Real-world experience with Ocrelizumab in the MSBase Registry
    Butzkueven, H.
    Spelman, T.
    Patti, F.
    Ozakbas, S.
    Eichau, S.
    Alroughani, R.
    Terzi, M.
    Boz, C.
    Grand'Maison, F.
    Grammond, P.
    Kalincik, T.
    Van Pesch, V.
    Lechner-Scott, J.
    Barnett, M.
    Kuhle, J.
    Hodgkinson, S.
    Skibina, O.
    Soysal, A.
    Butler, E.
    Slee, M.
    Prevost, J.
    Laureys, G.
    Macdonell, R.
    van Beek, J.
    Craveiro, L.
    Wormser, D.
    Muros-Le Rouzic, E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 539 - 540
  • [32] EARLY REAL-WORLD EXPERIENCE OF OCRELIZUMAB IN MS
    Harding, Katharine
    Ingram, Gillian
    Horton, Emma
    Owen, Helen
    Joseph, Fady
    Pearson, Owen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
  • [33] Ocrelizumab real-world safety and effectiveness in the two years of treatment in multiple sclerosis
    Vollmer, B.
    Declusin, A.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 294 - 295
  • [34] ACAPELLA: Real-World Experience with Ocrelizumab, 7-Year Data
    Greenawalt, Paige
    Fearey, Meg
    Stine, Sam
    Bouley, Andrew
    Lathi, Ellen
    Katz, Joshua
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 648 - 649
  • [35] Real-world Experience with Ocrelizumab - A Safety Analysis
    Bolling, Jamie
    Vasquez, Matthew
    Sollero, Carlos Eduardo Vervloet
    Carlson, Aaron
    Gyang, Tirisham
    NEUROLOGY, 2020, 94 (15)
  • [36] Real-world experience with ocrelizumab in the msbase registry
    Butzkueven, H.
    Spelman, T.
    Ozakbas, S.
    Kalincik, T.
    Boz, C.
    Buzzard, K.
    Skibina, O.
    Alroughani, R.
    Karabudak, R.
    Van der Walt, A.
    Lechner-Scott, J.
    Hodgkinson, S.
    Laureys, G.
    Van Hijfte, L.
    Terzi, M.
    Butler, E.
    Macdonell, R.
    Patti, F.
    Van Pesch, V.
    Slee, M.
    Barnett, M.
    Grammond, P.
    Prevost, J.
    Grand-Maison, F.
    Taylor, B.
    Kermode, A.
    Mccombe, P.
    Duquette, P.
    Prat, A.
    Girard, M.
    Eichau Madueno, S.
    Izquierdo, G.
    Soysal, A.
    Sanchez-Menoyo, J. L.
    Sotoca, J.
    Muros-Le Rouzic, E.
    Dirks, P.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 550 - 551
  • [37] ACAPELLA: Real-World Experience with Ocrelizumab, 6-Year Data
    Douglas, Elizabeth
    O'Shea, Isabella
    Greenawalt, Paige
    Bouley, Andrew
    Lathi, Ellen
    Katz, Joshua
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 979 - 980
  • [38] Real-world comparison of Rituximab and Ocrelizumab effectiveness in Multiple Sclerosis: a multicenter study
    Smolik, Krzysztof
    Camilli, Federico
    Del Prete, Claudia
    Foschi, Matteo
    Surcinelli, Andrea
    Curti, Erica
    Tsantes, Elena
    Ferri, Caterina
    Guareschi, Angelica
    Bazzurri, Veronica
    Montepietra, Sara
    Simone, Anna Maria
    Mancinelli, Luca
    Lugaresi, Alessandra
    Falzone, Francesca
    Piscaglia, Maria Grazia
    Granella, Franco
    Baldi, Eleonora
    Pesci, Ilaria
    Immovilli, Paolo
    Santangelo, Mario
    Cardi, Martina
    Fiore, Alessia
    De Napoli, Giulia
    Vitetta, Francesca
    Ferraro, Diana
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 373 - 374
  • [39] Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study
    Skoric, Magdalena Krbot
    Kes, Vanja Basic
    Grbic, Nevena
    Lazibat, Ines
    Pavelin, Sanda
    Zubonja, Tea Mirosevic
    Komso, Milica
    Piskac, Spomenka Kidemet
    Abicic, Ana
    Piskac, Dominik
    Adamec, Ivan
    Barun, Barbara
    Gabelic, Tereza
    Habek, Mario
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 89
  • [40] Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data
    Gitman, Victor
    Stavropoulos, Aphrodite
    Saenz, Victoria
    Pasquarelli, Noemi
    Zecevic, Dusanka
    Devonshire, Virginia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
12345